5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide

1252927-47-1

CAS-Nr.: 1252927-47-1

Englisch Name:: 5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide

Synonyma:: GSK-1071306;N-Demethyl Pazopanib;Pazopanib Impurity 13;Pazopanib Impurity 41;Pazopanib impurity 02;Pazopanib Impurity 56;Pazopanib metabolite M27;Pazopanib metabolite M27 HCl;Pazopanib N-Desmethyl Impurity;Pazopanib metabolite M27 Hydrochloride

CBNumber:: CB62695422

Summenformel:: C20H21N7O2S

Molgewicht:: 423.49144

MOL-Datei:: 1252927-47-1.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 26

5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide Eigenschaften

Schmelzpunkt:: >252°C (dec.)

storage temp.: Refrigerator

Löslichkeit: DMSO (Slightly), Ethyl Acetate (Slightly)

Aggregatzustand: Solid

Farbe: Pale Yellow

Sicherheit

5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide is a Pazopanib (P210925) impurity. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.

5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 26)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58
TargetMol Chemicals Inc.	+1-781-999-5354	support@targetmol.com	United States	19973	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8073	58
Klong Industrial Co., Ltd	519-68231162 13961227312	info@klongchem.com	China	150	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 13028896684	sales@rrkchem.com	China	56070	58
Shenzhen ruikai de biotechnology co., ltd.	0755-61348847 17820674378	2682116078@qq.com	China	7844	58
Shandong Wadesen Biotechnology Co. LTD	0531-88723173 18596073690	1047208234@qq.com	China	3901	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58

GSK-1071306
5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
Pazopanib Impurity 13
N-Demethyl Pazopanib
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methyl-
Pazopanib N-Desmethyl Impurity
Pazopanib Impurity 41
5-[[4-[(2,3-dimethylindazol-6-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
Pazopanib metabolite M27 HCl
Pazopanib metabolite M27
Pazopanib metabolite M27 Hydrochloride
Pazopanib impurity 02
Pazopanib Impurity 56
1252927-47-1
Metabolites & Intermediates, Pharmaceuticals, Intermediates & Fine Chemicals